Acute Myeloid Leukemia Research Today is a free monthly online journal that collates and summarizes the latest research about Acute Myeloid Leukemia, including details on aml, symptoms, treatment, information.

Volume 4 (2007), Issue 5 (May)

1. Surgical resection of persistent pulmonary fungus nodules and secondary prophylaxis are effective in preventing fungal relapse in patients receiving chemotherapy or bone marrow transplantation for leukemia.
   Bone Marrow Transplant, 39(10): 631-5. [Abstract] [Full-text]
2. Graphium basitruncatum fungemia in a patient with acute leukemia.
   J Clin Microbiol, 45(5): 1644-7. [Abstract] [Full-text]
3. Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1.
   Cancer Res, 67(9): 4491-8. [Abstract] [Full-text]
4. Mutations of the PTPN11 gene in therapy-related MDS and AML with rare balanced chromosome translocations.
   Genes Chromosomes Cancer, 46(6): 517-21. [Abstract] [Full-text]
5. Acute myeloid leukemia and myelodysplastic syndromes in older patients.
   J Clin Oncol, 25(14): 1908-15. [Abstract] [Full-text]
6. Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.
   Br J Haematol, 137(5): 387-400. [Abstract] [Full-text]
7. Early gene expression of acute myeloid leukemia in response to chemotherapy.
   Expert Rev Anticancer Ther, 7(5): 741-51. [Abstract] [Full-text]
8. Age has no influence on mobilization of peripheral blood stem cells in acute myeloid leukemia.
   Hematol Oncol, 25(2): 84-9. [Abstract] [Full-text]
9. Interpretation of interleukin-2 receptor alpha positive cells during induction chemotherapy for adult acute myelogenous leukaemia patients.
   Hematol Oncol, 25(2): 76-83. [Abstract] [Full-text]
10. Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples.
    Clin Chem, 53(6): 1153-5. [Abstract] [Full-text]
11. Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells.
    Mol Cancer, 6: 33. [Abstract] [Full-text]
12. LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro.
    Mol Cancer, 6: 31. [Abstract] [Full-text]
13. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study.
    Blood, 109(11): 4641-7. [Abstract] [Full-text]
14. Analysis of immunohistochemical markers in bone marrow sections to evaluate for myelodysplastic syndromes and acute myeloid leukemias.
    Appl Immunohistochem Mol Morphol, 15(2): 154-9. [Abstract] [Full-text]
15. The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients.
    Oncogene, 26(25): 3679-90. [Abstract] [Full-text]
16. HoxA10 activates transcription of the gene encoding mitogen-activated protein kinase phosphatase 2 (Mkp2) in myeloid cells.
    J Biol Chem, 282(22): 16164-76. [Abstract] [Full-text]
17. Isoform-specific potentiation of stem and progenitor cell engraftment by AML1/RUNX1.
    PLoS Med, 4(5): e172. [Abstract] [Full-text]

© 2004-2008 Acute Myeloid Leukemia Research Today. All Rights Reserved.